MCW

Medical College of Wisconsin Cancer Center Announces New Training Program to Boost Diversity in Cancer Research

Retrieved on: 
Montag, Februar 27, 2023
University of Wisconsin–Milwaukee, Doctor of Philosophy, Cell biology, Cancer, Prostate cancer, MD, MCW, University of Chicago Comprehensive Cancer Center, ACS, Anatomy, Alverno College, Research, Ace Institute of Health Sciences, Partnership, Neuroscience, Mount Mary University, Mentorship, Diversity, American Cancer Society, American Cancer Society Cancer Action Network, Korea Disease Control and Prevention Agency, Medical College of Wisconsin, Science, Student, Incidence, Medical college, Nursing

MILWAUKEE, Feb. 27, 2023 /PRNewswire/ -- The Medical College of Wisconsin (MCW) Cancer Center today announced a new 2-year training program to improve diversity, equity, and inclusion in cancer research. In partnership with Alverno College, Mount Mary University, UW-Milwaukee, and other Wisconsin universities, the program aims to develop a diverse cancer research workforce – one with the potential to impact cancer disparities in eastern Wisconsin.

Key Points: 
  • Effort Aims to Diversify Research Workforce, Address Regional Cancer Disparities
    MILWAUKEE, Feb. 27, 2023 /PRNewswire/ -- The Medical College of Wisconsin (MCW) Cancer Center today announced a new 2-year training program to improve diversity, equity, and inclusion in cancer research.
  • In partnership with Alverno College, Mount Mary University, UW-Milwaukee, and other Wisconsin universities, the program aims to develop a diverse cancer research workforce – one with the potential to impact cancer disparities in eastern Wisconsin.
  • Funded by the American Cancer Society's (ACS) Center for Diversity in Cancer Research Training , the MCW Cancer Center was one of eight institutions selected to offer the post-baccalaureate program which provides underrepresented students in science with an immersive experience that includes hands-on training in cancer research labs, access to research mentors, participation in community outreach efforts, and career development workshops.
  • Student research via MCW's program will focus on the molecular mechanisms of cancer and cancer health disparities, building on nearly 10 years of cancer disparities research at the MCW Cancer Center.

Mister Car Wash Announces Fourth Quarter and Fiscal Year 2022 Financial Results

Retrieved on: 
Donnerstag, Februar 23, 2023
Professional Services, Retail, Automotive, Other Automotive, Specialty, Finance, UWC, NYSE, EBITDA, Comparable, GAAP, MCW, Cryptocurrency, Video game, Reinsurance, Real estate

Mister Car Wash, Inc. (the “Company”) (NYSE: MCW), the nation’s largest car wash brand, today announced its financial results for the quarter and fiscal year ended December 31, 2022.

Key Points: 
  • Mister Car Wash, Inc. (the “Company”) (NYSE: MCW), the nation’s largest car wash brand, today announced its financial results for the quarter and fiscal year ended December 31, 2022.
  • “We reported another strong quarter, capping off an excellent year for our company,” said John Lai, Chairperson and CEO of Mister Car Wash. “Demand for our services remained steady and our retention of Unlimited Wash Club members remained consistent in the fourth quarter.
  • We opened thirteen new greenfield locations in the fourth quarter, a record quarterly number for the company.
  • UWC sales represented approximately 71% of total wash sales in the fourth quarter of 2022 compared to approximately 67% in the fourth quarter of 2021.

Mister Car Wash to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

Retrieved on: 
Donnerstag, Februar 9, 2023
Retail, Automotive, General Automotive, Other Automotive, Other Retail, Specialty, MCW, NYSE, Pharmaceutical industry, Auction, Cryptocurrency

Mister Car Wash, Inc. (the "Company" or "Mister"; NYSE: MCW), the nation’s largest car wash brand, today announced that its financial results for the fourth quarter and full year 2022 will be released after market close on Thursday, February 23, 2023.

Key Points: 
  • Mister Car Wash, Inc. (the "Company" or "Mister"; NYSE: MCW), the nation’s largest car wash brand, today announced that its financial results for the fourth quarter and full year 2022 will be released after market close on Thursday, February 23, 2023.
  • The Company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results.
  • Investors and analysts interested in participating in the call are invited to dial 855-209-8213 (international callers please dial 1-412-542-4146) approximately 10 minutes prior to the start of the call.
  • A live audio webcast of the conference call will be available online at https://ir.mistercarwash.com/ .

Be The Match BioTherapies® Launches Bioinformatics Consulting Services

Retrieved on: 
Mittwoch, Dezember 14, 2022
Research, Genetics, Clinical Trials, Stem Cells, Biotechnology, Other Health, Health, General Health, Science, MCW, Physician, Genetics, Match, MD, Center for International Blood and Marrow Transplant Research, HCT, HLA, Doctor of Philosophy, Partnership, Histocompatibility, Health, Patient, Science, Genotype, Collection, NMDP, FDA, Medical College of Wisconsin, KIR, Quality of life, Survival, National Marrow Donor Program, Onboarding, Medical college, Dentistry, Pharmaceutical industry, Research

Be The Match BioTherapies , an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced its new Bioinformatics Consulting Services , which blends the unique expertise, real-world data and assets of Be The Match BioTherapies and the CIBMTR (Center for International Blood and Marrow Transplant Research).

Key Points: 
  • Be The Match BioTherapies , an organization offering solutions for companies developing and commercializing cell and gene therapies, today announced its new Bioinformatics Consulting Services , which blends the unique expertise, real-world data and assets of Be The Match BioTherapies and the CIBMTR (Center for International Blood and Marrow Transplant Research).
  • Our Bioinformatics Consulting Services operate at the intersection of science and technology, and bridges the transition from cell culture to the clinic.
  • The new Bioinformatics Consulting Services help companies mitigate risk by using data-driven answers to make decisions that maximize clinical success and speed allogeneic therapies to market.
  • The Bioinformatics Consulting Services experts include Martin Maiers, Vice President, Research; Abeer Madbouly, Principal Bioinformatics Scientist; Michael Wright, Scientific Coordinator; Heather Stefanski, MD, PhD, Vice President, Medical Services; and Steve Devine, MD, Chief Medical Officer.

AHW Awards Nearly $1.5 Million in Seed Grants to Advance Health Research and Support Community Health Projects

Retrieved on: 
Mittwoch, Dezember 14, 2022
Faculty, MCW, AHW, Seed, Research, Biomedical Research, Cancer, Trustee, Cardiovascular disease, Community health, Public, Collaboration, Medical College of Wisconsin, MPH, Attention, Health equity, Health, Violence, Health literacy, Medical college, Pharmaceutical industry, Medicine, MD

MILWAUKEE, Dec. 14, 2022 /PRNewswire/ -- The Advancing a Healthier Wisconsin Endowment (AHW) will provide $1,474,350 in funding to 31 projects selected through a competitive application process focused on promising biomedical research and community-based initiatives aimed at improving the health and well-being of Wisconsin residents.

Key Points: 
  • "Our mission at AHW is to serve as a catalyst for positive change in the health of Wisconsin communities," said AHW Director Jesse Ehrenfeld, MD, MPH.
  • Of the 31 proposals approved for funding, 17 represent research projects led by MCW faculty.
  • For more information on projects funded by AHW, including seed grant awards that take effect in January 2023, visit the funded projects page on the AHW website.
  • Since 2004, AHW has invested more than $336 million in 600 health research, workforce development, and community health initiatives statewide.

Mister Car Wash, Inc. Announces Participation in the 2022 Morgan Stanley Global Consumer & Retail Conference

Retrieved on: 
Mittwoch, November 30, 2022
Retail, Specialty, Other Retail, Internet, Environment, Mr., MCW, NYSE, Conference, Online shopping

Mister Car Wash, Inc. (the Company) (NYSE: MCW), the nations largest car wash brand, today announced that the Company is scheduled to participate in a fireside chat discussion at the 2022 Morgan Stanley Global Consumer & Retail Conference on Tuesday, December 6, 2022, at 1:00 pm Eastern Time.

Key Points: 
  • Mister Car Wash, Inc. (the Company) (NYSE: MCW), the nations largest car wash brand, today announced that the Company is scheduled to participate in a fireside chat discussion at the 2022 Morgan Stanley Global Consumer & Retail Conference on Tuesday, December 6, 2022, at 1:00 pm Eastern Time.
  • The fireside chat will be webcast live over the internet and can be accessed on the Companys Investor Relations website, ir.mistercarwash.com.
  • Headquartered in Tucson, AZ, Mister Car Wash, Inc. (NYSE: MCW) operates 420 car washes nationwide and has the largest car wash subscription program in North America.
  • With over 25 years of car wash experience, the Mister team is focused on operational excellence and delivering a memorable customer experience through elevated hospitality.

Children Treated With Remestemcel-L Show Long-Term Survival Through Four Years in Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

Retrieved on: 
Dienstag, November 22, 2022
Marketing, Pediatrics, Medical college, MCW, Inflammation, GVHD, Center for International Blood and Marrow Transplant Research, Australian Securities Exchange, Research, MESO, NMDP, Hematopoietic stem cell transplantation, McMillan, Lymphatic system, BLA, Doctor of Philosophy, Immune system, Patient, SWOT, Phenotype, National Marrow Donor Program, BMT, Risk, FDA, MSB, National Farm Medicine Center, Mortality, Heart, Death, Disease, BAT, Medical College of Wisconsin, Mesoblast, Duke University Hospital, Blood, Chief, MBA, Database, Quality of life, Survival, Pharmaceutical industry, Management, Dentistry, Pathology

NEW YORK, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced top-line long-term survival results for remestemcel-L from its pivotal Phase 3 trial (GVHD-001) in children with steroid-refractory acute graft-versus-host disease (SR-aGVHD). The results showed durable survival through 4 years of follow-up. These new long-term survival data are a key component of the company’s BLA resubmission to the FDA for remestemcel-L in the treatment of children with SR-aGVHD, a life-threatening condition with no approved treatments for children under 12 years.

Key Points: 
  • Overall survival in the remestemcel-L cohort was 63% at 1 year, 51% at 2 years, and 49% at 4 years, with median survival of 2 to 3 years.
  • Acute GVHD occurs in approximately 50% of patients who receive an allogeneic bone marrow transplant (BMT).
  • Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, biologic-resistant inflammatory bowel disease, and acute respiratory distress syndrome.
  • Outcomes and predictors of response in steroid-refractory acute graft-versus-host disease: single-center results from a cohort of 203 patients.

Rose Biosciences Uncovers New Path to Address the Obesity Pandemic

Retrieved on: 
Montag, November 14, 2022
Doctor of Philosophy, Metabolism, MCW, Obesity, Population, Medical College of Wisconsin, Awareness, Appetite, Medical college, Partnership, Acceleration, Weight loss, Health care, Company, Microbiology, Diet, Bacteria, Research, Immunology, Trustee, Life, Clinical trial, Exercise, Pharmaceutical industry, Soft drink

MILWAUKEE, Nov. 14, 2022 /PRNewswire/ -- A groundbreaking discovery by a Medical College of Wisconsin (MCW) microbiologist and partnership with one of its trustees has led to the founding of Rose Biosciences – a biotech company pioneering a new approach to obesity treatment.

Key Points: 
  • Specifically, the molecule resides in bacterial communities within the human body and can influence resting metabolic rates within those communities.
  • "Current treatments for obesity focus on diet, exercise, and pharmacologic options that influence satiety or appetite.
  • "The primary goal of Rose Biosciences is to support bringing this MCW laboratory discovery to clinical trial," said Dr. Mortara.
  • The Rose Biosciences team has secured pre-seed funding and is currently taking next steps to bring this discovery forward, including licensing and additional intellectual property development.

Mister Car Wash Welcomes Luke Hartke

Retrieved on: 
Montag, Oktober 31, 2022
Retail, Other Automotive, General Automotive, Automotive, Specialty, Growth, CEO, Mergers and acquisitions, Acquisition, MCW, SEC, NYSE, Industry, Risk, COVID-19, Terminology, Corporate development, Private Securities Litigation Reform Act, Company, Multimedia, Mr., Environment, Forward-looking statement, Mergers & Acquisitions, Retail, Risk management

Mister Car Wash, Inc. (the Company or Mister NYSE: MCW), the nations largest car wash company announced the addition of Luke Hartke as Vice President of Mergers & Acquisitions.

Key Points: 
  • Mister Car Wash, Inc. (the Company or Mister NYSE: MCW), the nations largest car wash company announced the addition of Luke Hartke as Vice President of Mergers & Acquisitions.
  • View the full release here: https://www.businesswire.com/news/home/20221031005666/en/
    Luke Hartke joins Mister Car Wash as Vice President, Mergers & Acquisitions.
  • Prior to joining Mister Car Wash, Hartke spent much of his career at Caseys General Store, a Fortune 400 company with 2,500 locations located primarily in the Midwest.
  • Headquartered in Tucson, AZ, Mister Car Wash, Inc. (NYSE: MCW) operates more than 400 car washes nationwide and has the largest car wash subscription program in North America.

Mister Car Wash to Report Third Quarter of Fiscal 2022 Financial Results on November 10, 2022

Retrieved on: 
Donnerstag, Oktober 27, 2022
Other Retail, Retail, Other Automotive, Automotive, Specialty, MCW, Company, NYSE, Environment, Mr., Online shopping

Mister Car Wash, Inc. (the "Company" or "Mister"; NYSE: MCW), the nations largest car wash brand, today announced that its financial results for the third quarter of fiscal 2022 will be released after market close on Thursday, November 10, 2022.

Key Points: 
  • Mister Car Wash, Inc. (the "Company" or "Mister"; NYSE: MCW), the nations largest car wash brand, today announced that its financial results for the third quarter of fiscal 2022 will be released after market close on Thursday, November 10, 2022.
  • The Company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results.
  • Headquartered in Tucson, AZ, Mister Car Wash, Inc. (NYSE: MCW) operates more than 400 car washes nationwide and has the largest car wash subscription program in North America.
  • With over 25 years of car wash experience, the Mister team is focused on operational excellence and delivering a memorable customer experience through elevated hospitality.